Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Amryt presents data from pivotal EASE study of Filsuvez in epidermolysis bullosa

Nov. 2, 2020

Leo Pharma presents pooled safety data from clinical trials of tralokinumab

Nov. 2, 2020

FDA clears IND for phase IIa study of OLX-10010 for hypertrophic scars

Nov. 2, 2020

Topline results from phase II AURORA trial of avacopan reported

Oct. 30, 2020

MediWound completes enrollment in phase II pediatric study of NexoBrid

Oct. 30, 2020

First patient dosed in phase II study of BBP-589

Oct. 29, 2020

Phase II study of SHR-0302 in atopic dermatitis meets primary and secondary endpoints

Oct. 27, 2020

First patient dosed in phase IIa study of ATI-1777

Oct. 21, 2020

Genfleet Therapeutics patents RIP-1 inhibitors

Oct. 16, 2020

AnaptysBio reports topline data from phase II GALLOP study of imsidolimab in GPP

Oct. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 28, 2025
New drugs with the same old resistance tricks?
BioWorld
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in 2020. And figures are rising, with...
OS Therapies heading to FDA with positive osteosarcoma data
BioWorld
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies Inc. anticipates a regulatory filing...
Vilastobart set apart? Xilio phase II combo performs in CRC
BioWorld
“The [colorectal cancer field is moving, and thankfully it’s moving quickly,” said Marwan Fakih, gastrointestinal specialist at City of Hope, speaking about...